Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development.
Deng R, Zhao X, Qu Y, Chen C, Zhu C, Zhang H, Yuan H, Jin H, Liu X, Wang Y, Chen Q, Huang J, Yu J.
Deng R, et al. Among authors: wang y.
Oncotarget. 2015 Apr 20;6(11):9355-69. doi: 10.18632/oncotarget.3323.
Oncotarget. 2015.
PMID: 25823821
Free PMC article.